Genscript Biotech Corp (GNNSF) Stock Price & News

GNNSF:OTCMKTS

Genscript Biotech Corp

$1.60

0.00%

(0.00) 1D

Jun 1, 3:52:33 PM GMT-4 · USD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for GNNSF...

Mkt. cap

28.49B

Avg. vol.

73.00

Volume

76.00K

52-wk high

$2.42

52-wk low

$1.30

Beta

0.51

Shares outstanding

2.19B

No. of employees

Mkt. cap

28.49B

Avg. vol.

73.00

Volume

76.00K

52-wk high

$2.42

52-wk low

$1.30

Beta

0.51

Shares outstanding

2.19B

No. of employees

News stories

From sources across the web

Simply Wall Street

19 minutes ago

Profitable AI Stocks One Connects Data One Cools Racks One Commands Governments

Simply Wall Street

1 hour ago

Pilgrim's Pride Shifts Toward Higher Value Boneless Chicken Production

CNBC

1 day ago

Elon Musk becomes world's first trillionaire as SpaceX begins trading on the Nasdaq

AOL.com

3 hours ago

SETM Is Up 27% YTD and 150% Over a Year. The S&P 500? Not Even Close.

About Genscript Biotech Corp

CEO-

Employees6.16K

Founded2002

HeadquartersPiscataway, New Jersey, United States

SectorHealth care

Websitegenscript.com

All values in USD	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	259.39M	259.39M	220.38M	220.38M
Cost of goods sold	99.07M	99.07M	104.09M	104.09M
Cost of revenue	99.07M	99.07M	104.09M	104.09M
Research and development expenses	15.66M	15.66M	19.96M	19.96M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	55.32M	55.32M	58.71M	58.71M
Operating expense	70.77M	70.77M	78.21M	78.21M
Total operating expenses	169.84M	169.84M	182.30M	182.30M
Operating income	89.55M	89.55M	38.08M	38.08M
Other non operating income	9.33M	9.33M	946.50K	946.50K
EBT including unusual items	-59.50K	-59.50K	-235.21M	-235.21M
EBT excluding unusual items	3.37M	3.37M	-27.78M	-27.78M
Income tax expense	12.21M	12.21M	18.72M	18.72M
Effective tax rate	-20,527.73%	-20,527.73%	-7.96%	-7.96%
Other operating expenses	-	-	-	-
Net income	-12.73M	-12.73M	-253.68M	-253.68M
Net profit margin	-4.91%	-4.91%	-115.11%	-115.11%
Earnings per share	-	-	-	-
Interest and investment income	4.96M	4.96M	8.09M	8.09M
Interest expense	-4.60M	-4.60M	-4.05M	-4.05M
Net interest expenses	355.50K	355.50K	4.05M	4.05M
Depreciation and amortization charges	-	-	-	-
EBITDA	104.46M	104.46M	54.34M	54.34M
Gain or loss from assets sale	11.00K	11.00K	423.50K	423.50K

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research